Polanczyk GV, Salum GA, Sugaya LS, et al. Annual research review: a meta-analysis of the worldwide prevalence of mental disorders in children and adolescents. J Child Psychol Psychiatry. 2015;56(3):345–65.
Klau J, Bernardo CD, Gonzalez-Chica DA, et al. Trends in prescription of psychotropic medications to children and adolescents in Australian primary care from 2011 to 2018. Aust N Z J Psychiatry. 2022;56(11):1477–90.
Steinhausen HC. Recent international trends in psychotropic medication prescriptions for children and adolescents. Eur Child Adolesc Psychiatry. 2015;24(6):635–40.
Parkin R, Bennett K, Nicholas FM, et al. Recent trends in psychotropic medication use in children and adolescents in Ireland. Eur Child Adolesc Psychiatry. 2024. https://doi.org/10.1007/s00787-024-02530-7.
Bais Y, Hermans RA, Schuiling-Veninga CC, et al. Comparison of antipsychotic drug use among Dutch Youth before and after implementation of the Youth Act (2010–2019). Eur Child Adolesc Psychiatry. 2023;32:1427–34.
MacAvin M, Teeling M, Bennett KE. Trends in attention-deficit and hyperactivity disorder (ADHD) medications among children and young adults in Ireland: a repeated cross-sectional study from 2005 to 2015. BMJ Open. 2020;10(4):e035716.
Article PubMed PubMed Central Google Scholar
Sørensen AM, Wesselhöeft R, Andersen JH et al. Trends in use of attention deficit hyperactivity disorder medication among children and adolescents in Scandinavia in 2010–2020. Eur Child Adolesc Psychiatry. 2023;32:2049–56.
Dai Cao TX, Fraga LF, Fergusson E, et al. Prescribing trends of antidepressants and psychotropic coprescription for youths in UK primary care, 2000–2018. J Affect Disord. 2021;287:19–25.
O’Sullivan K, Boland F, Reulbach U, et al. Antidepressant prescribing in Irish children: secular trends and international comparison in the context of a safety warning. BMC Pediatr. 2015;15:119.
Article PubMed PubMed Central Google Scholar
Mental Health Commission. Independent Review of the provision of Child and Adolescent Mental Health Services (CAMHS) in the State by the Inspector of Mental Health Services. 2023. https://www.mhcirl.ie/publications/independent-review-provision-child-and-adolescent-mental-healthservices-camhs-state. Accessed 25 April 2024
Maskey DS, Report on the look-back review into child and adolescent mental health services county MHS Area 2022. https://www.hse.ie/eng/services/news/newsfeatures/south-kerry-camhs-review/. Accessed 23 Jan 2023
Radojčić MR, Pierce M, Hope H, et al. Trends in antipsychotic prescribing to children and adolescents in England: cohort study using 2000–19 primary care data. Lancet Psychiatry. 2023;10(2):119–28.
Sinnott SJ, Bennett K, Cahir C. Pharmacoepidemiology resources in Ireland-an introduction to pharmacy claims data. Eur J Clin Pharmacol. 2017;73(11):1449–55.
Article CAS PubMed PubMed Central Google Scholar
Central Statistics Office. Census 2016. https://data.cso.ie/. Accessed 01 Nov 2022.
Bliddal M, Rasmussen L, Andersen JH, et al. Psychotropic medication use and psychiatric disorders during the COVID-19 pandemic among danish children, adolescents, and young adults. JAMA Psychiat. 2023;80(2):176–80.
Wood SJ, Ilomäki J, Gould J, et al. Dispensing of psychotropic medications to australian children and adolescents before and during the COVID-19 pandemic, 2013–2021: a retrospective cohort study. Med J Aust. 2023;219(1):18–25.
Harris E, Antidepressant prescriptions for female teens surged after pandemic. JAMA. 2024. https://doi.org/10.1001/jama.2024.2093
Boland F, Galvin R, Reulbach U, et al. Psychostimulant prescribing trends in a paediatric population in Ireland: a national cohort study. BMC Pediatr. 2015;15:118.
Article PubMed PubMed Central Google Scholar
Rasmussen L, Jensen PB, Reutfors J, et al. Treatment patterns of antidepressants in children and adolescents in Scandinavia. Eur Child Adolesc Psychiatry. 2024; https://doi.org/10.1007/s00787-024-02433-7.
Skogli EW, Teicher MH, Andersen PN, et al. ADHD in girls and boys–gender differences in co-existing symptoms and executive function measures. BMC Psychiatry. 2013;13:298.
Article PubMed PubMed Central Google Scholar
Barczyk ZA, Rucklidge JJ, Eggleston M, et al. Psychotropic medication prescription rates and trends for New Zealand children and adolescents 2008–2016. J Child Adolesc Psychopharmacol. 2020;30(2):87–96.
Vickers ML, Chan HY, Elliott S, et al. Stimulant medications in the management of bulimia nervosa and anorexia nervosa in patients with and without comorbid attention deficit hyperactivity disorder: a systematic review. Eat Behav. 2024;54: 101908.
Stoltz-Andersen M, Wesselhoeft R, Ernst M, et al. Use of ADHD medication among danish children and adolescents from 2010–2020—a nationwide study. Eur Psychiatry. 2022;1(65):S82.
Sonuga-Barke EJ, Halperin JM. Developmental phenotypes and causal pathways in attention deficit/hyperactivity disorder: potential targets for early intervention? J Child Psychol Psychiatry. 2010;51(4):368–89. https://doi.org/10.1007/s00787-024-02428-4
Lynch S, McDonnell T, Leahy D, et al. Prevalence of mental health disorders in children and adolescents in the Republic of Ireland: a systematic review. Ir J Psychol Med. 2023;40(1):51–62.
Article CAS PubMed Google Scholar
National Institute for Health and Care Excellence, NICE Guideline NG87: Attention deficit hyperactivity disorder: diagnosis and management. 2019. https://www.nice.org.uk/guidance/ng87. Accessed 25 April 2024
Hickey L, Hannigan A, O’Regan A, et al. Psychological morbidity among young adults attending primary care: a retrospective study. Early Interv Psychiatry. 2018;12(1):22–9.
Driscoll DJ, McCarthy S, Antipsychotic prescribing: national findings of children and adolescents attending mental health services in Ireland. Eur Child Adolesc Psychiatry. 2024. https://doi.org/10.1007/s00787-024-02428-4
Keller MB, Ryan ND, Strober M, et al. Efficacy of paroxetine in the treatment of adolescent major depression: a randomized, controlled trial. J Am Acad Child Adolesc Psychiatry. 2001;40(7):762–72.
Article CAS PubMed Google Scholar
Angold A, Costello EJ. Puberty and depression. Child Adolesc Psychiatr Clin N Am. 2006;15(4):919–37.
Dean AJ, McDermott BM, Marshall RT. Psychotropic medication utilization in a child and adolescent mental health service. J Child Adolesc Psychopharmacol. 2006;16(3):273–85.
Dayabandara M, Hanwella R, Ratnatunga S, et al. Antipsychotic-associated weight gain: management strategies and impact on treatment adherence. Neuropsychiatr Dis Treat. 2017;13:2231–41.
Article PubMed PubMed Central Google Scholar
Vitiello B. An international perspective on pediatric psychopharmacology. Int Rev Psychiatry. 2008;20(2):121–6.
Zolezzi M, Alamri M, Shaar S, et al. Stigma associated with mental illness and its treatment in the Arab culture: a systematic review. Int J Soc Psychiatry. 2018;64(6):597–609.
Alotaibi W, Cultural and gender differences in attitudes towards religiosity, mental health stigma, and psychotropic medication use: saudi arabian versus american college students, In: Barry University. 2020
Valtuille Z, Acquaviva E, Trebossen V, et al. Psychotropic medication prescribing for children and adolescents after the onset of the COVID-19 pandemic. JAMA Netw Open. 2024;7(4): e247965.
Comments (0)